Undifferentiated pleomorphic sarcoma of the floor of mouth: A rare case
We report the second case of undifferentiated pleomorphic sarcoma of the floor of mouth. (Source: Journal of Oral and Maxillofacial Pathology)
Source: Journal of Oral and Maxillofacial Pathology - February 4, 2023 Category: ENT & OMF Authors: Anjali Sharma Praveena Vyas Deshant Agarwal Source Type: research

A League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic Sarcoma
Opinion statementOver the last decade in soft tissue sarcoma (STS) research, the shifting landscape towards more precise subtype classification and the increasing study of novel therapeutic strategies has prompted a need to highlight current knowledge of effective subtype specific therapies. Undifferentiated pleomorphic sarcoma (UPS), formerly known as malignant fibrous histiocytoma (MFH), is among the most common subtypes of STS arising in the trunk or extremities of adults. Administration of systemic chemotherapy is the primary management in locally advanced and metastatic UPS. While anthracycline-based chemotherapy cont...
Source: Current Treatment Options in Oncology - February 2, 2023 Category: Cancer & Oncology Source Type: research

Some CNS sarcomas seen: A 22-year series
CONCLUSIONS: Few primary or metastatic, adult or pediatric, CNS/spinal sarcomas required nomenclature updates; almost all had been satisfactorily classified at the time of diagnosis, using immunohistochemistry, FISH, or fusion results.PMID:36708209 | DOI:10.5414/NP301512 (Source: Clinical Neuropathology)
Source: Clinical Neuropathology - January 28, 2023 Category: Pathology Authors: Bette K Kleinschmidt-DeMasters Ahmed Gilani Source Type: research

Some CNS sarcomas seen: A 22-year series
CONCLUSIONS: Few primary or metastatic, adult or pediatric, CNS/spinal sarcomas required nomenclature updates; almost all had been satisfactorily classified at the time of diagnosis, using immunohistochemistry, FISH, or fusion results.PMID:36708209 | DOI:10.5414/NP301512 (Source: Clinical Neuropathology)
Source: Clinical Neuropathology - January 28, 2023 Category: Pathology Authors: Bette K Kleinschmidt-DeMasters Ahmed Gilani Source Type: research

Some CNS sarcomas seen: A 22-year series
CONCLUSIONS: Few primary or metastatic, adult or pediatric, CNS/spinal sarcomas required nomenclature updates; almost all had been satisfactorily classified at the time of diagnosis, using immunohistochemistry, FISH, or fusion results.PMID:36708209 | DOI:10.5414/NP301512 (Source: Clinical Neuropathology)
Source: Clinical Neuropathology - January 28, 2023 Category: Pathology Authors: Bette K Kleinschmidt-DeMasters Ahmed Gilani Source Type: research

Some CNS sarcomas seen: A 22-year series
CONCLUSIONS: Few primary or metastatic, adult or pediatric, CNS/spinal sarcomas required nomenclature updates; almost all had been satisfactorily classified at the time of diagnosis, using immunohistochemistry, FISH, or fusion results.PMID:36708209 | DOI:10.5414/NP301512 (Source: Clinical Neuropathology)
Source: Clinical Neuropathology - January 28, 2023 Category: Pathology Authors: Bette K Kleinschmidt-DeMasters Ahmed Gilani Source Type: research

Some CNS sarcomas seen: A 22-year series
CONCLUSIONS: Few primary or metastatic, adult or pediatric, CNS/spinal sarcomas required nomenclature updates; almost all had been satisfactorily classified at the time of diagnosis, using immunohistochemistry, FISH, or fusion results.PMID:36708209 | DOI:10.5414/NP301512 (Source: Clinical Neuropathology)
Source: Clinical Neuropathology - January 28, 2023 Category: Pathology Authors: Bette K Kleinschmidt-DeMasters Ahmed Gilani Source Type: research